Carl Byrnes
Stock Analyst at Northland Capital Markets
(2.38)
# 2,629
Out of 5,044 analysts
25
Total ratings
52.94%
Success rate
10.9%
Average return
Main Sectors:
Stocks Rated by Carl Byrnes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNWV SANUWAVE Health | Initiates: Outperform | $55 | $31.02 | +77.30% | 1 | Sep 3, 2025 | |
| BWAY BrainsWay | Maintains: Outperform | $15 → $19 | $17.01 | +11.70% | 4 | Aug 14, 2025 | |
| BLFS BioLife Solutions | Maintains: Outperform | $28 → $31 | $28.04 | +10.56% | 2 | Jan 8, 2025 | |
| TLSI TriSalus Life Sciences | Initiates: Outperform | $13 | $5.02 | +149.00% | 1 | Oct 25, 2024 | |
| MDAI Spectral AI | Initiates: Outperform | $6 | $2.12 | +183.02% | 1 | Aug 12, 2024 | |
| COCH Envoy Medical | Initiates: Outperform | n/a | $0.81 | - | 1 | Dec 21, 2023 | |
| AMRN Amarin Corporation | Maintains: Market Perform | $40 → $25 | $19.24 | +29.94% | 1 | Jul 19, 2023 | |
| CDIO Cardio Diagnostics Holdings | Initiates: Outperform | $240 | $3.91 | +6,038.11% | 1 | May 22, 2023 | |
| VTVT vTv Therapeutics | Maintains: Outperform | $60 → $80 | $21.19 | +277.54% | 4 | Aug 17, 2022 | |
| MDXG MiMedx Group | Initiates: Outperform | $23 | $6.73 | +241.75% | 3 | Jul 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $30 → $24 | $2.90 | +727.59% | 4 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $2,000 | $2.21 | +90,397.74% | 1 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.18 | - | 1 | Sep 27, 2017 |
SANUWAVE Health
Sep 3, 2025
Initiates: Outperform
Price Target: $55
Current: $31.02
Upside: +77.30%
BrainsWay
Aug 14, 2025
Maintains: Outperform
Price Target: $15 → $19
Current: $17.01
Upside: +11.70%
BioLife Solutions
Jan 8, 2025
Maintains: Outperform
Price Target: $28 → $31
Current: $28.04
Upside: +10.56%
TriSalus Life Sciences
Oct 25, 2024
Initiates: Outperform
Price Target: $13
Current: $5.02
Upside: +149.00%
Spectral AI
Aug 12, 2024
Initiates: Outperform
Price Target: $6
Current: $2.12
Upside: +183.02%
Envoy Medical
Dec 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $0.81
Upside: -
Amarin Corporation
Jul 19, 2023
Maintains: Market Perform
Price Target: $40 → $25
Current: $19.24
Upside: +29.94%
Cardio Diagnostics Holdings
May 22, 2023
Initiates: Outperform
Price Target: $240
Current: $3.91
Upside: +6,038.11%
vTv Therapeutics
Aug 17, 2022
Maintains: Outperform
Price Target: $60 → $80
Current: $21.19
Upside: +277.54%
MiMedx Group
Jul 26, 2021
Initiates: Outperform
Price Target: $23
Current: $6.73
Upside: +241.75%
May 5, 2021
Maintains: Market Perform
Price Target: $30 → $24
Current: $2.90
Upside: +727.59%
Oct 22, 2018
Initiates: Outperform
Price Target: $2,000
Current: $2.21
Upside: +90,397.74%
Sep 27, 2017
Initiates: Outperform
Price Target: n/a
Current: $1.18
Upside: -